What is the main business of Mu42?

The main business activity of Mu42 focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 29, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Reformacka 6, 35-026 Rzeszów.

Who is on the management board?

The management board consists of: Kamil Adam Mieszkowski (Member of the Management Board) and Maciej Paweł Ciemny (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 7,500 (approx. $2,026).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $46,492, representing an increase of 36493.6% compared to 2023.

No, in 2024 the company was not profitable, reporting a net loss of $12,747. For comparison, in 2023 the loss was $2,743, meaning the company increased its loss by 341.4%.

Which cost dominates operating expenses?

The largest operating cost category falls under depreciation and amortization. This category amounted to $58,186 in 2024, representing 99% of all operating expenses.

Mu42sp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-12-29

Share capital

7,500.00 PLN

Registered address

ul. Reformacka 6, 35-026 Rzeszów, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 370 days for 2024).

2025not filed
202420/07/2026
202329/07/2024
202230/06/2023
202117/10/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Research and experimental development on biotechnology202 / 386

Top 52%

Division · Scientific research and development1,101 / 1,952

Top 56%

Sector · Professional, scientific and technical activities24,525 / 39,196

Top 63%

Voivodeship · Podkarpackie11,372 / 16,365

Top 69%

Country · Poland339,858 / 495,935

Top 69%

Results vs industry

Revenue

This companyUSD 46.49kMedianUSD 55.66kAverageUSD 2.70m

Net profit

This companyUSD -12.75kMedianUSD -1.27kAverageUSD -92.16k

Operating costs

This companyUSD 59.05kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 234.98kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Kamil Adam Mieszkowskiage 36 – Management Board Member

Maciej Paweł Ciemnyage 35 – Management Board Member

Manner of representation

The following is authorized to sign and make declarations of will on behalf of the company: 1. in the case of a one-person management board, the sole member of the management board acting independently; 2. in the case of a multi-member management board, at least two members acting jointly.

Ownership

Owner	Shares	Share value	Stake
ASI Rds Fund sp. z o.o. + limited partnership	50	$675.31	33.3333%
Maciej Paweł Ciemnyage 35	50	$675.31	33.3333%
Kamil Adam Mieszkowskiage 36	50	$675.31	33.3333%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-09-01.

mBank
50 1140 2004 0000 3302 8098 1350

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Dec 6, 2022	Aid for SME access to finance — aid for start-ups	$210.8K$210,832	Dyrektor Narodowego Centrum Badań i Rozwoju
Jan 25, 2021	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$13,558$13,558	Rzeszowska Agencja Rozwoju Regionalnego S.A.

Competitors

Name	Revenue	Website
Pominnosp. z o.o.	$65,991.17	pominno.pl
Luna Laboratorysp. z o.o.	$61,894.23	lunalab.pl
GenomtecS.A.	$54,746.36	genomtec.com
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.	$54,163.54	geneza.eu
Receptonsp. z o.o.	$50,611.05	receptonbiotech.com
Biostat Research And Developmentsp. z o.o.	$50,225.77	biostat.com.pl
Zawamedsp. z o.o.	$43,909.06	zawamed.pl
Stenocoatsp. z o.o.	$36,665.21	stenocoat.com
Immbionicsp. z o.o.	$31,756.23	immbionic.com.pl
Platforma Badań Genetycznychsp. z o.o.	$28,558.39	zdrowegeny.pl

Change history

Date	Event
2023-09-21	Address change (Ul. Stanisława Moniuszki 11, 35-015, Rzeszów → Ul. Reformacka 6, 35-026, Rzeszów)
2023-04-14	Share capital increase (5,000.00 PLN → 7,500.00 PLN)
2023-04-14	PKD change (Added: 62.01.Z, 62.09.Z, 63.11.Z, 63.12.Z, 63.99.Z, 72.20.Z)
2022-06-06	Name change (Langpro → Mu42)
2022-06-06	PKD change (Removed: 9 codes; Added: 3 codes)

FAQ

Last updated: 2026-07-20